U.S. SECURITIES AND EXCHANGE COMMISSION

                     WASHINGTON, D. C.  20549


                           FORM 12b-25

                   NOTIFICATION OF LATE FILING


[ ] Form 10-K   [ ] Form 20F   [ ] Form 11-K   [X] Form 10-Q
[ ] Form N-SAR

For the Period Ended September 30, 2002.

     [ ] Transition Report on Form 10-K
     [ ] Transition Report on Form 20-F
     [ ] Transition Report on Form 11-K
     [ ] Transition Report on Form 10-Q
     [ ] Transition Report on Form N-SAR

For the Transition Period Ended ________________

          Nothing in this form shall be construed to imply that
the Commission has verified any information contained herein.

          If the notification relates to a portion of the filing
checked above, identify the Item(s) to which the notification
relates:

                 PART I - REGISTRANT INFORMATION

Full Name of Registrant:      SANGUINE CORPORATION

Address of Principal          101 East Green Street, Suite #11
Executive Office:             Pasadena, California 91105

                PART II - RULES 12b-25 (b) and (c)

If the subject report could not be filed without unreasonable
effort or expense and the Registrant seeks relief pursuant to
Rule 12b-25(b) [Section 23,047], the following should be completed.
(Check box if appropriate)

     [X]  (a)  The reasons described in reasonable detail in Part
III of this form could not be eliminated without unreasonable
effort or expense;

     [ ]  (b)    (i) The subject annual report, semi-annual
report, transition report on Form 10-K, Form 20F, 11-K or Form
N-SAR, or portion thereof will be filed on or before the
fifteenth calendar day following the prescribed due date; or

     [X]       (ii) The subject quarterly report or transition
report on Form 10-Q, or portion thereof will be filed on or
before the fifth calendar day following the prescribed due date.

     [ ]  (c)  The accountant's statement or other exhibit
required by Rule 12b-25(c) has been attached if applicable.

                       PART III - NARRATIVE

          Management and counsel are reviewing the unaudited financial
statements and procedures to ensure that managment can certify to the contents
of the Quarterly Report and the financial statements as required by the
Sarbanes-Oxley Act.

                   PART IV - OTHER INFORMATION

          (1)  Name and address of person to contact in regard to
this notification:

               Branden T. Burningham, Esq.
               455 East 500 South, Suite 205
               Salt Lake City, Utah  84111
               Telephone:  (801) 363-7411

          (2)  Have all other periodic reports required under
Section 13 or 15(d) of the Securities Exchange Act of 1934 or
Section 30 of the Investment Company Act of 1940 during the
preceding 12 months or for such shorter period that the
Registrant was required to file such report(s) been filed?  If
the answer is no, identify report(s).
                                             [X] Yes  [ ] No

          (3)  Is it anticipated that any significant change in
results of operations from the corresponding period for the last
fiscal year will be reflected by the earnings statements to be
included in the subject report or portion thereof?
                                             [ ] Yes  [X] No

          If so, attach an explanation of the anticipated change,
both narratively and quantitatively, and, if appropriate, state
the reasons why a reasonable estimate of the results cannot be made.


          SANGUINE CORPORATION has caused this notification to be
signed on its behalf by the undersigned thereunto duly authorized.

Date: 11/14/02                      /s/Thomas C. Drees
     ----------                     ----------------------------
                                    Thomas C. Drees, Ph.D., MBA
                                    CEO, President and Chairman of the
                                    Board of Directors